Primecare Pharma Private Limited, a active private limited company, was established on 14 March 2018 in Bangalore, Karnataka, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U74999KA2018PTC111171. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.50 Cr.
Formerly known as First Excel Enterprises Private Limited. Employing 22 professional, Its leadership includes Sayed Jawad Wajid (Additional Director), Venkatapathi Naidu Bharani (Additional Director), Thummalakuntla Venkata Sivudu (Additional Director). It holds ₹20.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.450/19, 3Rd Cross Wilson Garden, Bangalore, Karnataka, 560027.
U74999KA2018PTC111171
111171
14 March 2018
₹1.50 Cr
₹1.50 Cr
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Primecare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sayed Jawad Wajid | Additional Director | 30 Jan 2025 | Current |
| Venkatapathi Naidu Bharani | Additional Director | 25 Jun 2023 | Current |
| Thummalakuntla Venkata Sivudu | Additional Director | 25 Jun 2023 | Current |
| Mohamed Umar Nayaz | Director | 14 Mar 2018 | Current |
| Parveez Ahmed | Director | 14 Mar 2018 | Current |
| Quazi Abdul Wali | Additional Director | 06 May 2025 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Primecare Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 24.67% increase. The company also saw a substantial improvement in profitability, with a 37.91% increase in profit. The company's net worth observed a substantial decline by a decrease of 61.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Primecare Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹200,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Feb 2025 | State Bank Of India | ₹20.00 Cr | Open |
Explore comprehensive loan charge details -
Primecare Pharma has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Primecare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Primecare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Quazi Abdul Wali was appointed as a Additional Director was appointed as a Additional Director on 06 May 2025 & has been associated with this company since 6 months 26 days . was documented.
The activity A charge with State Bank Of India amounted to Rs. 20.00 Cr with Charge ID 101046264 was registered on 14 Feb 2025. was completed.
Progress on Sayed Jawad Wajid was appointed as a Additional Director was appointed as a Additional Director on 30 Jan 2025 & has been associated with this company since 9 months 30 days . was documented.
The activity Primecare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Primecare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore. was recorded as a recent event.
The activity Venkatapathi Naidu Bharani was appointed as a Additional Director was appointed as a Additional Director on 25 Jun 2023 & has been associated with this company since 2 years 5 months . was completed.
The CIN of Primecare Pharma Private Limited is U74999KA2018PTC111171.
Primecare Pharma Private Limited is headquartered at No.450/19, 3Rd Cross Wilson Garden, Bangalore, Karnataka, 560027.
Primecare Pharma Private Limited was incorporated on 14 March 2018.
The current directors of Primecare Pharma Private Limited are
The primary industry of Primecare Pharma Private Limited is Hospital And Medical Care.
Primecare Pharma Private Limited is unlisted.
The authorized capital of Primecare Pharma Private Limited is ₹1.50 Cr, and the paid-up capital is ₹1.50 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX